Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19
-
- Eric J. Lenze
- Department of Psychiatry, School of Medicine, Washington University in St Louis, St Louis, Missouri
-
- Caline Mattar
- Division of Infectious Diseases, Department of Internal Medicine, School of Medicine, Washington University in St Louis, St Louis, Missouri
-
- Charles F. Zorumski
- Department of Psychiatry, School of Medicine, Washington University in St Louis, St Louis, Missouri
-
- Angela Stevens
- Department of Psychiatry, School of Medicine, Washington University in St Louis, St Louis, Missouri
-
- Julie Schweiger
- Department of Psychiatry, School of Medicine, Washington University in St Louis, St Louis, Missouri
-
- Ginger E. Nicol
- Department of Psychiatry, School of Medicine, Washington University in St Louis, St Louis, Missouri
-
- J. Philip Miller
- Division of Biostatistics, Informatics Institute, School of Medicine, Washington University in St Louis, St Louis, Missouri
-
- Lei Yang
- Department of Psychiatry, School of Medicine, Washington University in St Louis, St Louis, Missouri
-
- Michael Yingling
- Department of Psychiatry, School of Medicine, Washington University in St Louis, St Louis, Missouri
-
- Michael S. Avidan
- Department of Anesthesiology, School of Medicine, Washington University in St Louis, St Louis, Missouri
-
- Angela M. Reiersen
- Department of Psychiatry, School of Medicine, Washington University in St Louis, St Louis, Missouri
書誌事項
- タイトル別名
-
- A Randomized Clinical Trial
収録刊行物
-
- JAMA
-
JAMA 324 (22), 2292-, 2020-12-08
American Medical Association (AMA)